Search Results - "LICEA, Monica"
-
1
Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer
Published in Molecular cancer therapeutics (01-08-2018)“…We have developed MGD007 (anti-glycoprotein A33 x anti-CD3), a DART protein designed to redirect T cells to target gpA33 expressing colon cancer. The gpA33…”
Get full text
Journal Article -
2
Development of an Fc-Enhanced Anti―B7-H3 Monoclonal Antibody with Potent Antitumor Activity
Published in Clinical cancer research (15-07-2012)“…The goal of this research was to harness a monoclonal antibody (mAb) discovery platform to identify cell-surface antigens highly expressed on cancer and…”
Get full text
Journal Article -
3
Abstract 1498: Development of an IL13Ralpha2 x CD3 bispecific DART® protein for redirected T-cell killing of solid tumors
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Introduction. IL13Rα2 is a membrane-bound protein expressed on a number of malignant tumors, but not at significant levels in most normal tissues. Clinically…”
Get full text
Journal Article -
4
Abstract 38: Target validation, antibody discovery and preclinical data supporting ADAM9 as an antibody-drug conjugate therapeutic target for solid tumors
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Introduction: A target-unbiased approach based on intact cell immunizations with fetal progenitor cells and cancer stem cells, followed by an…”
Get full text
Journal Article -
5
Abstract 3217: MGD013, a bispecific PD-1 x LAG-3 Dual-Affinity Re-Targeting (DART®) protein with T-cell immunomodulatory activity for cancer treatment
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Introduction: The combination of monoclonal antibodies (mAbs) that targets the immune checkpoint molecules CTLA-4 and PD-1 has shown clinical benefit beyond…”
Get full text
Journal Article -
6
Abstract 3763: Identification of gpA33 as a marker expressed on colon cancer stem cell lines
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Introduction: Recent studies have implied that solid tumors including colon cancer, can arise from tissue-specific stem cells. Defined serum-free culture…”
Get full text
Journal Article -
7
Abstract 2725: Preclinical development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent anti-tumor activity
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Antigens that are tumor-specific or over-expressed on cancer cells represent opportunities for developing target-specific antibody-based therapeutics…”
Get full text
Journal Article